envelop
protein
env
human
immunodefici
viru
type
class
fusion
glycoprotein
protrud
viral
envelop
homotrim
compos
noncovalentlylink
heterodim
recognit
viral
receptor
coreceptor
surfac
subunit
activ
fusion
machineri
transmembran
tm
subunit
fig
result
insert
ntermin
fusion
peptid
region
fp
target
cell
membran
prefus
intermedi
conform
connect
cellular
membran
viral
envelop
expos
extend
two
heptad
repeat
hr
region
intermedi
conform
quickli
resolv
stabl
sixhelix
bundl
conform
fold
back
onto
central
form
coiledcoil
trimerofdim
predispos
oppos
membran
suffici
proxim
subsequ
envelop
fusion
plasma
membran
viral
content
deliveri
lipid
mix
subsequ
membran
fusion
mediat
membran
proxim
extern
region
mper
fig
hydrophob
region
tm
domain
mper
induc
fusionrequir
membran
perturb
direct
interact
membran
sequenti
align
reveal
high
conserv
mper
among
differ
group
fig
particular
contain
two
conserv
sequenc
element
contribut
membran
perturb
function
one
enrich
aromat
amino
acid
particular
trp
fig
cholesterolinteract
cterminu
previou
studi
shown
ala
substitut
five
trp
residu
abrog
abil
mpercontain
peptid
partit
destabil
liposom
membran
context
substitut
mper
inhibit
membran
fusion
event
fusion
pore
expans
viral
entri
furthermor
mper
cterminu
lwyik
show
sequenc
characterist
cholesterol
recognitioninteract
amino
acid
consensu
crac
motif
lv
x
x
rk
cholesterol
enrich
viral
envelop
also
cell
membran
lipid
raft
viral
receptor
enrich
viral
entri
make
membran
rigid
counteract
viral
entri
c
terminu
mper
facilit
induct
membran
destabil
subsequ
fusion
cholesterolenrich
liposom
membran
membran
destabil
abil
mper
sequenc
implic
design
viral
fusion
inhibitor
two
first
fusion
inhibitor
synthet
peptid
contain
sequenc
nterminu
mper
fig
sequenc
enabl
inhibitor
bind
expos
prefus
intermedi
conform
therebi
halt
format
addit
mper
sequenc
act
inhibitor
later
stage
viral
entri
possibl
anchor
peptid
cellular
membran
last
four
residu
wnwf
membran
anchor
abil
two
fusion
inhibitor
correl
antivir
activ
still
peptid
fusion
inhibitor
includ
partial
mper
sequenc
without
ctermin
sequenc
due
high
variat
mutat
rate
env
protein
fusion
inhibitor
constantli
challeng
drug
resist
issu
mper
conserv
expos
access
region
therefor
could
addit
target
design
potenti
fusion
inhibitor
apart
role
viral
entri
env
also
interact
host
cellular
membran
biosynthesi
traffick
viral
bud
site
type
transmembran
protein
env
cotransl
transloc
rough
endoplasm
reticulum
er
transport
golgi
complex
matur
subsequ
proteolyt
process
result
trimer
transport
cholesterolrich
plasma
membran
region
eg
lipid
raft
follow
secretori
pathway
studi
sarscov
sever
respiratori
syndrom
associ
corona
viru
observ
trp
residu
mper
modul
select
incorpor
spike
protein
lipid
raft
unpublish
observ
see
fig
howev
salzwedel
colleagu
found
neither
delet
trp
substitut
mutat
mper
affect
env
matur
steadyst
level
effect
incorpor
viru
particl
describ
role
trp
residu
membraneact
mper
sequenc
antihiv
fusion
inhibitor
design
surpris
role
biosynthesi
viral
structur
protein
six
peptid
rang
amino
acid
aa
design
contain
mper
sequenc
full
length
ctermin
truncat
penta
substitut
fig
antivir
activ
test
singleround
infect
assay
use
pseudoviru
dimer
antivir
peptid
shown
enhanc
structur
stabil
number
interact
site
thu
antivir
efficaci
therefor
also
test
peptid
n
ctermin
dimer
env
mutat
trp
residu
mper
region
also
construct
examin
role
trp
residu
biosynthesi
matur
traffick
viral
incorpor
viral
structur
protein
monomer
peptid
custom
synthes
synpeptid
co
ltd
shanghai
china
dimer
peptid
pepscan
presto
bv
amsterdam
netherland
antibodi
chessi
vif
obtain
nih
aid
research
refer
reagent
program
polyclon
rabbit
antinef
antibodi
obtain
thermo
fisher
scientif
inc
monoclon
mous
antibodi
obtain
sigma
antibodi
previous
describ
secondari
antibodi
hrpconjug
polyclon
goat
antirabbit
immunoglobulin
hrpconjug
polyclon
rabbit
antimous
immunoglobulin
obtain
dako
hltat
cat
tzmbl
cat
cell
line
obtain
nih
aid
research
refer
reagent
program
cultur
dulbecco
modifi
eagl
medium
life
technolog
supplement
fetal
bovin
serum
life
technolog
penicillinstreptomycin
life
technolog
express
plasmid
env
nef
neg
regul
factor
vpu
virion
protein
u
strain
kindli
provid
dr
stefan
schwartz
lund
univers
lund
sweden
contain
vpudefici
genom
signal
sequenc
env
truncat
construct
quick
chang
ii
xl
stratagen
specif
fragment
ecoribamhi
clone
creat
vpu
start
codon
mutat
ata
contain
xma
cleavag
site
immedi
upstream
vpu
use
primer
pair
b
forward
revers
mutat
introduc
encod
vpu
signal
peptid
aa
length
use
primer
pair
forward
revers
xmainhei
fragment
construct
mutant
direct
insert
creat
sitedirect
mutagenesi
carri
primer
pair
forward
revers
introduc
signal
sequenc
mutat
ecorinhei
fragment
result
mutant
construct
subclon
saiincoi
fragment
direct
transfer
creat
construct
use
quick
chang
ii
agil
technolog
construct
use
primer
pair
forward
revers
cctcctactatcattatgaataattttatatacgccagcgcatttgttatgttaaaccaattccacaaacttgc
construct
use
primer
pair
b
forward
gaatgaacaagaattattggaattagataaagcggcaagtttggcgaatgcgtttaacataacaaattggctgtggta
revers
taccacaccacatttgttatgttaaacgcattcgccaaacttgccgctttatctaattccaataattcttgttcattc
construct
use
primer
pair
mutat
plasmid
sequenc
nucleotid
sequenc
primer
hltat
cell
x
cotransfect
provir
clone
env
vpuexpress
plasmid
use
fugenehd
roch
product
mutant
pseudotyp
use
transfect
instead
cell
cultur
supernat
collect
hour
h
posttransfect
clarifi
centrifug
filtrat
use
virion
precipit
store
use
viral
particl
precipit
clarifi
cell
cultur
supernat
vol
vol
polyethylen
glycol
contain
nacl
precipit
particl
concentr
centrifug
time
g
min
viru
pellet
dissolv
radioimmunoprecipit
assay
ripa
buffer
contain
mm
trishcl
ph
triton
deoxychol
mm
nacl
mm
edta
sodium
dodecyl
sulfat
sd
supplement
complet
proteas
inhibitor
cocktail
roch
cellfre
pseudotyp
viru
either
preincub
peptid
variou
concentr
h
appli
directli
infect
tzmbl
cell
tzmbl
cell
contain
integr
copi
ltr
long
termin
repeat
driven
luciferas
report
gene
seventytwo
h
postinfect
infect
pseudoviru
assess
luciferas
activ
use
oneglo
luciferas
assay
system
promega
pseudotyp
calcul
base
luciferas
activ
infect
tzmbl
cell
use
method
cutoff
valu
set
time
background
signal
effect
concentr
peptid
inhibit
viral
infect
estim
graphpad
prism
valu
estim
doserespons
curv
curvefit
sigmoid
doserespons
nonlinear
regress
model
prism
graphpad
softwar
use
percentag
inhibit
data
log
valu
peptid
concentr
cytotox
effect
peptid
tzmbl
cell
determin
prestoblu
cell
viabil
assay
lifetechnolog
singapor
accord
manufactur
protocol
briefli
peptid
differ
concentr
ad
tzmbl
cell
seed
plate
upon
h
incub
prestoblu
cell
viabil
reagent
ad
cell
incub
min
result
absorb
valu
record
baselin
final
spectrum
obtain
normal
nm
valu
nm
valu
circular
dichroism
spectroscopi
analysi
perform
studi
secondari
structur
monomer
peptid
trifluoroethanol
tfe
tfe
use
mimic
hydrophob
environ
membran
fusion
junction
measur
made
chirascan
circular
dichroism
spectromet
appli
photophys
fifti
peptid
dissolv
tfe
subject
measur
three
repeat
cell
pathlength
hellma
uk
ltd
sampl
measur
step
resolut
measur
speed
bandwidth
baselin
measur
tfe
three
repeat
final
spectrum
gener
subtract
averag
sampl
spectrum
baselin
spectrum
follow
smooth
savitskygolay
filter
secondari
structur
peptid
estim
deconvolut
respect
circular
dichroism
spectra
use
cdsstr
deconvolut
algorithm
dichroweb
cutoff
nrmsd
valu
set
hltat
cell
x
express
wt
mutant
pseudotyp
lyse
ripa
buffer
ice
centrifug
mix
laemmli
reduc
buffer
precipit
pseudotyp
viral
particl
dissolv
ripa
buffer
also
prepar
laemmli
reduc
buffer
cell
lysat
viru
lysat
resolv
sdspolyacrylamid
gel
electrophoresi
page
transfer
nitrocellul
membran
immunoblot
antisera
follow
hrpconjug
antirabbit
secondari
antibodi
env
express
antisera
follow
hrpconjug
antirabbit
secondari
antibodi
express
antinef
antibodi
follow
hrpconjug
antirabbit
secondari
antibodi
nef
express
antivif
follow
hrpconjug
antimous
secondari
antibodi
vif
express
follow
hrpconjug
antimous
secondari
antibodi
express
membran
either
expos
film
analyz
g
box
chemi
syngen
band
intens
quantifi
imagej
softwar
level
cellfre
lysat
virusproduc
hltat
cell
cell
cultur
supernat
quantifi
autom
system
architect
abbott
standard
curv
gener
use
known
concentr
curvefit
linear
nonregress
model
prism
graphpad
softwar
prior
measur
sampl
dilut
concentr
within
linear
rang
standard
curv
six
mpercontain
peptid
fig
rang
aa
prepar
acetyl
ntermini
amid
ctermini
test
fusionentri
inhibitor
pseudotyp
ensur
studi
earli
event
viral
replic
cycl
pseudoviru
system
allow
singl
replic
cycl
employ
pseudoviru
particl
produc
cotransfect
env
vpuexpressiondefici
provir
vector
env
vpu
nef
express
vector
gener
viral
particl
capabl
enter
infect
target
cell
capabl
give
rise
infecti
secondgener
viral
particl
pseudotyp
particl
preincub
six
mpercontain
peptid
h
ad
target
cell
tzmbl
cell
stabli
express
tatrespons
luciferas
report
gene
allow
monitor
success
entri
viral
protein
product
inhibit
infect
monitor
measur
luciferas
express
h
postinfect
peptid
contain
entir
exclus
mper
sequenc
inhibit
viral
entri
infect
respect
fig
inclus
five
residu
nterminu
gener
peptid
decreas
valu
respect
howev
ntermin
extens
addit
nine
sixteen
residu
result
peptid
lead
substanti
increas
antivir
potenc
howev
ad
hydrophil
residu
greatli
enhanc
solubl
structur
stabil
mpercontain
peptid
allow
applic
design
peptid
dimer
elabor
section
determin
necess
conserv
mper
ctermin
cholesterolinteract
motif
lwyik
antivir
effect
peptid
mper
ctermin
sequenc
nwlwyik
delet
activ
peptid
creat
peptid
delet
abrog
antivir
activ
fail
inhibit
viral
infect
concentr
fig
addit
import
enrich
aromat
residu
trp
mper
region
examin
mutat
trp
ala
exclus
mpercontain
peptid
result
peptid
interestingli
substitut
trp
abolish
antivir
activ
peptid
even
enhanc
viral
infect
dosedepend
manner
fig
increas
viral
infect
inhibit
viral
infect
mperderiv
peptid
due
cytotox
incub
tzmbl
cell
peptid
h
result
statist
differ
cell
viabil
control
dmsotreat
peptidetr
cell
fig
investig
structurefunct
relationship
mpercontain
peptid
inhibit
entri
secondari
structur
peptid
determin
circular
dichroism
fig
region
anoth
class
viral
fusion
glycoprotein
spike
protein
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
previous
shown
larg
synthet
peptid
deriv
region
serv
control
peptid
follow
cd
studi
peptid
prepar
tfe
mimic
lipid
environ
juxtamembran
junction
ntermin
extens
residu
gener
increas
helic
mpercontain
peptid
delet
ctermin
sequenc
nwlwyik
chang
secondari
structur
drastic
fig
mimic
increasingli
lipid
environ
transit
mper
undergo
membran
fusion
tfe
concentr
increas
increas
tfe
concentr
gradual
exhibit
alphahel
conform
first
minimum
spectra
shift
nm
nm
nm
estim
content
increas
fig
contrast
peptid
trp
replac
ala
exhibit
canon
alphahel
spectra
high
content
start
tfe
fig
indic
import
trp
residu
maintain
structur
plastic
mper
sequenc
next
investig
antivir
effect
peptid
could
enhanc
dimer
either
n
cterminu
hypothes
ntermin
dimer
mpercontain
peptid
would
mimic
fusionact
oligomer
state
mper
thu
enhanc
bind
affin
interact
partner
eg
fp
therebi
possess
improv
viral
inhibitori
effect
dimer
peptid
construct
parallel
peptid
chain
either
two
carboxyl
termini
two
amino
termini
use
chemoselect
ligat
strategi
obtain
ntermin
link
dimer
dn
monomer
peptid
synthes
addit
ntermin
cy
residu
ligat
via
thiazolidin
linkag
linker
molecul
consist
two
ser
branch
ly
fig
ctermin
peptid
dimer
dc
synthes
mbha
resin
ligat
ctermin
linker
via
amino
function
group
linker
fig
n
ctermin
dimer
synthes
peptid
ctermin
link
dimer
also
synthes
due
synthet
difficulti
ntermin
dimer
obtain
dimer
peptid
test
abil
inhibit
viral
entri
use
singleround
infect
assay
tzmbl
cell
describ
monomer
peptid
fig
ntermin
dimer
enhanc
antivir
potenc
fig
valu
increas
potenc
compar
monomer
respect
fig
contrast
ctermin
dimer
decreas
potenc
valu
elev
fold
respect
fig
meanwhil
ctermin
dimer
inconsist
effect
antivir
potenc
valu
decreas
valu
significantli
increas
respect
monomer
form
fig
summari
data
indic
antivir
activ
benefit
ntermin
dimer
mpercontain
peptid
cytotox
effect
monomer
dimer
peptid
observ
vitro
tzmbl
cell
concentr
determin
prestoblu
cell
viabil
assay
fig
circular
dichroism
data
suggest
substitut
induc
mper
peptid
commit
predominantli
helic
structur
regardless
environment
lipid
fig
pose
possibl
mutat
may
also
affect
secondari
structur
mper
sequenc
within
precursor
env
glycoprotein
turn
may
disturb
proper
fold
er
affect
biosynthesi
way
eventu
lead
viral
defect
investig
sitedirect
mutagenesi
perform
envexpress
plasmid
gener
three
mutant
five
trp
three
ntermin
trp
two
ctermin
trp
mper
sequenc
substitut
ala
result
construct
term
respect
examin
effect
trp
substitut
env
express
viral
matur
context
virusproduc
cell
bud
viral
particl
hltat
cell
cotransfect
env
vpuexpressiondefici
provir
vector
describ
wt
mutant
produc
pseudotyp
viral
particl
contain
wt
env
accordingli
express
particl
term
hiv
wt
hiv
hiv
hiv
h
posttransfect
found
env
level
cell
lysat
contain
hiv
hiv
hiv
lower
lysat
contain
hiv
wt
fig
steadyst
intracellular
level
cell
produc
hiv
hiv
hiv
approxim
hiv
wt
p
p
p
n
fig
strike
effect
trp
mutat
observ
viral
structur
protein
specif
deriv
protein
genom
encod
three
structur
protein
precursor
protein
env
gagpol
env
translat
er
transport
site
viral
assembl
plasma
membran
via
secretori
pathway
gagpol
express
cytosol
two
viral
cytosol
precursor
structur
protein
meet
env
plasma
membran
directli
indirectli
interact
cytosol
tail
env
recruit
assembl
viral
particl
viral
bud
viral
proteas
within
gagpol
activ
lead
process
gagpol
among
protein
capsid
protein
commonli
use
detect
viral
particl
product
analysi
level
cell
produc
wt
mutant
reveal
h
posttransfect
cell
produc
hiv
approxim
p
n
higher
compar
cell
produc
hiv
wt
fig
howev
two
mutant
hiv
hiv
show
increas
level
intracellular
fig
analysi
perform
use
autom
system
archiect
abbot
accredit
detect
human
serum
also
perform
inhous
valid
experi
infect
cell
presenc
proteas
inhibitor
indinavir
confirm
system
detect
within
matur
process
precursor
protein
correspond
cell
lysat
therefor
subject
analysi
western
blot
find
clearli
confirm
elev
intracellular
level
hiv
compar
hiv
wt
fig
two
viral
protein
vif
nef
blot
serv
control
transfect
effici
express
standard
result
indic
intracellular
elev
p
n
result
increas
express
level
hiv
mutant
compar
hiv
wt
p
n
fig
extracellular
level
hiv
express
cultur
analyz
autom
system
archiect
abbot
found
higher
hiv
wt
p
n
consist
increas
intracellular
express
level
mutant
fig
smaller
increas
extracellular
level
detect
hiv
p
n
express
cultur
fig
addit
viral
particl
isol
equal
volum
respect
cell
cultur
supernat
subject
analysi
env
western
blot
follow
densitometr
analysi
compar
hiv
wt
moder
decreas
env
level
among
mutant
viral
particl
contrast
content
isol
hiv
viru
particl
elev
approxim
respect
fig
line
elev
level
detect
cell
cultur
lysat
supernat
autom
system
architect
indic
increas
hiv
viral
particl
product
result
increas
intracellular
express
similar
increas
content
observ
hiv
particl
isol
fig
influenc
trp
substitut
ala
mper
viral
entri
infect
also
test
ad
equal
volum
respect
cell
free
cultur
supernat
tzmbl
cell
fortyeight
hour
postinfect
tatactiv
express
luciferas
tzmbl
cell
measur
show
contrast
hiv
wt
mutant
particl
hiv
hiv
hiv
lost
abil
infect
tzmbl
cell
fig
data
collect
suggest
substitut
trp
ala
mper
sequenc
decreas
intracellular
express
level
consequ
moder
reduc
env
incorpor
viral
particl
mutat
significantli
influenc
intracellular
express
level
particular
substitut
mper
significantli
elev
intracellular
express
subsequ
viral
particl
product
furthermor
substitut
trp
ala
render
viral
particl
noninfecti
accord
previou
literatur
mper
ldkwaslwnwfnitnwlwyik
induc
membranefusionrequir
membran
perturb
viral
envelop
cellular
membran
two
conserv
membraneact
sequenc
element
enrich
aromat
residu
eg
trp
ctermin
cholesterol
interact
motif
lwyik
show
membran
activ
sequenti
element
mper
vital
mpercontain
short
peptidyl
fusion
inhibitor
omiss
ctermin
motif
lwyik
substitut
abrog
activ
peptid
antivir
activ
could
enhanc
ndimer
cdimer
studi
peptid
contain
entir
mper
sequenc
inhibit
pseudotyp
entri
infect
valu
ntermin
extens
five
amphipath
residu
deriv
region
aa
enhanc
antivir
effect
reduc
half
ntermin
extens
enhanc
antivir
effect
substanti
probabl
sequenc
includ
enough
residu
mediat
stabl
interact
peptid
viral
format
instead
enhanc
antivir
efficaci
addit
five
amphipath
residu
correl
subtl
increas
helic
result
peptid
maintain
gener
structur
profil
estim
respect
circular
dichroism
spectrum
context
amphipath
sequenc
upstream
mper
serv
extens
induc
nterminu
mper
fusogen
transform
extend
conform
helix
upon
increas
local
lipid
suggest
addit
five
residu
ntermin
amphipath
sequenc
confer
peptid
stabl
conform
capac
interact
lead
enhanc
antivir
efficaci
format
suggest
induc
secondari
structur
transform
mper
nterminu
also
result
quaternari
structur
rearrang
oligomer
meanwhil
mper
ctermini
neighbor
stay
monomer
assum
extend
platform
destabil
cholesterolenrich
lipid
bilay
like
crac
motif
lwyik
data
show
delet
ctermin
sequenc
includ
conserv
crac
motif
mpercontain
peptid
abrog
antivir
effect
suggest
membraneact
sequenc
play
essenti
role
antivir
mechan
peptid
peptid
dimer
data
support
inclus
free
ctermini
membran
interact
mper
peptid
import
inhibit
entri
constrain
peptid
ctermini
ctermin
result
antivir
effect
peptid
unenhanc
previou
studi
nomura
etal
also
observ
ctermin
trimer
fail
enhanc
antivir
efficaci
significantli
presum
trimer
constrain
membraneact
mper
sequenc
offset
activ
enhanc
due
potenti
cooper
interact
sequenc
viral
enrich
trp
residu
mper
second
import
membraneact
characterist
exhibit
class
fusion
glycoprotein
trp
contain
larg
indol
sidechain
prefer
juxtamembran
interfac
protein
facilit
proteinmembran
interact
stabil
protein
structur
studi
examin
influenc
trp
residu
design
fusion
inhibitor
substitut
indol
sidechain
five
trp
residu
alkyl
moieti
ala
surprisingli
result
peptid
promot
viral
infect
rather
inhibit
phenotyp
also
observ
alasubstitut
trp
residu
sarscov
mper
peptid
data
indic
signific
membraneact
element
mpercontain
peptid
crac
motif
trp
residu
inhibit
entri
agreement
previou
find
increas
membran
reactiv
owe
inclus
mper
ntermin
sequenc
ldkwaslwnwf
correl
enhanc
antivir
effect
peptid
note
data
demonstr
involv
ctermin
crac
motif
lwyik
facilit
viral
inhibit
short
mpercontain
peptid
minim
inclus
sequenc
asid
involv
membran
fusion
event
trp
residu
also
shown
modul
interact
mper
viral
domain
viral
entri
specif
mper
interact
fp
form
continu
hydrophob
track
along
promot
membran
juxtaposit
shortli
interact
stabil
transit
prefus
postfus
conform
mper
andor
fp
could
temporarili
expos
vulner
dominantneg
bind
peptidyl
fusion
inhibitor
studi
recent
shown
mper
sarscov
spike
protein
interact
intern
fp
ifp
trpdepend
manner
studi
substitut
also
result
mpercontain
peptid
lose
dosedepend
inhibit
coronaviru
entri
correl
disrupt
mperifp
interact
previous
shown
mediat
mperfp
interact
ala
substitut
peptid
could
lead
diminish
affin
peptid
fp
henc
contribut
loss
antivir
effect
peptid
furthermor
substitut
prematur
predispos
peptid
final
helic
conform
lose
lipidityinduc
structur
plastic
suggest
potenti
interact
mper
viral
region
fp
could
also
conformationdepend
transit
mper
extend
helic
conform
could
result
intermedi
speci
interact
take
place
whilst
ctermin
dimer
fail
enhanc
antivir
efficaci
peptid
studi
ntermin
dimer
lower
valu
data
would
suggest
ntermin
dimer
mpercontain
peptid
mimic
fusionact
oligomer
state
mper
thu
enhanc
bind
affin
interact
partner
eg
fp
membran
therebi
improv
antivir
effect
optim
length
linker
monom
could
explor
enhanc
flexibl
unit
peptid
may
enhanc
cooper
interact
peptid
multim
differenti
effect
n
cdimer
antivir
effect
mpercontain
peptid
previous
observ
group
sarscov
model
viru
fig
n
ctermin
dimer
peptid
contain
protein
mper
sequenc
prepar
describ
paper
enhanc
inhibit
respect
antivir
effect
pseudotyp
sarscov
compar
monomer
peptid
mper
contain
neighbor
epitop
broadli
neutral
antibodi
includ
antibodi
antibodi
antibodi
shown
neutral
differ
strain
primari
isol
administr
cocktail
anim
model
despit
proven
difficult
tetram
peptid
mimet
contain
mper
sequenc
elicit
broadli
neutral
antibodi
guinea
pig
rise
potenti
immunogen
problem
mperderiv
antivir
peptid
howev
immun
respons
expect
induc
major
advers
effect
host
elicit
antihivmp
antibodi
could
probabl
immunolog
toler
host
may
even
help
control
hiv
replic
direct
evid
host
immunolog
toler
provid
recognit
two
autoantigen
human
kynureninas
splice
factor
subunit
furthermor
contain
epitop
clinic
proven
safe
effect
presenc
crossreact
antibodi
shown
act
synergist
inhibit
viral
infect
addit
neutral
capac
antibodi
requir
function
env
trimer
probabl
would
neutral
mperderiv
peptid
antivir
effect
nevertheless
prospect
develop
mperderiv
peptidyl
entri
inhibitor
potenti
elicit
immunolog
respons
examin
investig
final
peptid
test
differ
subtyp
confirm
antivir
activ
env
interact
host
membran
fusionentri
biosynthesi
traffick
viral
bud
substitut
five
trp
ala
mper
antivir
peptid
result
predominantli
adopt
helic
structur
regardless
environment
lipid
suggest
trp
residu
could
equal
vital
secondari
structur
mper
region
within
consequ
substitut
could
hamper
proper
fold
function
investig
biolog
relev
mper
trp
residu
biosynthesi
env
viral
protein
previous
salzwedel
et
al
found
trp
mutat
mper
affect
incorpor
env
virion
effect
mutat
seen
env
level
cell
lysat
plasma
membran
observ
transfect
hltat
cell
express
pseudotyp
ala
substitut
five
trp
ntermin
three
trp
ctermin
two
trp
residu
although
moder
lower
steadyst
intracellular
intravir
level
without
affect
migrat
pattern
compar
wt
discrep
find
may
due
differ
assay
use
quantifi
env
immunoprecipit
use
patient
serum
versu
immunoblot
interestingli
observ
mutat
env
upregul
express
capsid
protein
upregul
precursor
protein
despit
differenti
biosynthesi
pathway
env
result
gener
agre
previou
understand
env
express
inhibit
steadyst
intracellular
level
shown
downregul
express
env
could
execut
protein
level
env
cytoplasm
tail
rna
level
action
via
rev
respons
element
within
env
gene
studi
upregul
protein
intracellular
intravir
level
proport
reduct
env
protein
level
interestingli
ntermin
three
trp
ctermin
two
trp
substitut
gave
much
higher
increas
five
trp
replac
ala
henc
remain
open
question
anoth
distinct
mechan
mutat
env
mper
upregul
gag
express
besid
lower
intracellular
env
level
env
respons
receptorcoreceptor
recognit
membran
fusion
viral
entri
independ
induc
assembl
bud
viruslik
particl
live
cell
vitro
deriv
protein
dictat
proper
matur
size
morpholog
bud
virion
essenti
viral
infect
data
indic
trp
residu
env
mper
import
biosynthesi
env
anoth
major
viral
structur
protein
could
collect
affect
viral
fit
addit
factor
besid
absenc
membraneact
trp
indol
ring
sidechain
fail
viral
entri
observ
previou
studi
confirm
studi
summari
find
suggest
activ
particip
membraneact
element
within
mper
eg
trp
event
requir
proteinmembran
interact
viral
entri
assembl
result
indic
import
five
trp
residu
ctermin
sequenc
nwlwyik
mper
design
futur
mperbas
fusion
inhibitor
offer
insight
understand
viral
structur
protein
biosynthesi
role
mper
trp
residu
modul
viral
content
gag
protein
might
guid
discoveri
potenti
therapeut
target
infect
